ARENA PHARMACEUTICALS INC's ticker is and the CUSIP is 40047952. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $396,000 | -40.1% | 226,400 | -41.5% | 0.00% | -50.0% |
| Q2 2016 | $661,000 | +76.3% | 386,700 | +103.3% | 0.01% | +60.0% |
| Q1 2016 | $375,000 | -55.1% | 190,200 | -56.7% | 0.01% | -50.0% |
| Q4 2015 | $835,000 | -21.8% | 439,400 | -21.4% | 0.01% | -33.3% |
| Q3 2015 | $1,068,000 | -75.4% | 558,900 | -40.3% | 0.02% | -75.4% |
| Q2 2015 | $4,346,000 | -17.7% | 936,700 | -22.5% | 0.06% | -26.5% |
| Q1 2015 | $5,282,000 | +7.3% | 1,208,800 | -14.8% | 0.08% | +12.2% |
| Q4 2014 | $4,924,000 | -14.0% | 1,418,900 | +3.8% | 0.07% | -15.9% |
| Q3 2014 | $5,725,000 | -22.7% | 1,366,400 | +8.1% | 0.09% | -22.8% |
| Q2 2014 | $7,405,000 | +48.4% | 1,263,600 | +59.5% | 0.11% | +35.7% |
| Q1 2014 | $4,990,000 | +2.5% | 792,100 | -4.8% | 0.08% | +15.1% |
| Q4 2013 | $4,868,000 | +11.0% | 832,200 | -0.0% | 0.07% | -13.1% |
| Q3 2013 | $4,386,000 | – | 832,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 832,200 | $4,868,000 | 0.07% |